Global Spinal Muscular Atrophy Market Is Estimated To Witness High Growth Owing To Advanced Therapeutics Development
Spinal Muscular Atrophy Market The global Spinal Muscular Atrophy (SMA) market is estimated to be valued at US$1,600.6 million in 2022 and is expected to exhibit a CAGR of 13.3% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Spinal Muscular Atrophy is a rare genetic disorder characterized by the loss of motor neurons in the spinal cord and brainstem, leading to muscle weakness and atrophy. The market offers a range of therapeutics that aim to manage the symptoms and slow down the progression of the disease. These therapeutics provide significant advantages by improving the quality of life for patients and reducing the burden on caregivers. The growing need for effective treatments and the increasing prevalence of SMA are driving the growth of the market. B) Market Key Trends: One key trend in the Spinal Muscular Atrophy market is the development of advanced therapeutics. The market has seen significa